Brand Name: Besponsa
Generic Name: inotuzumab ozogamicin
Primary Class: CD22-directed Antibody Interactions [MoA]
SPL Set ID: cc7014b1-c775-411d-b374-8113248b4077 view on Dailymed | RXCUI: 1942954
Manufacturer Name: Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc.
| Package NDC | Description |
|---|---|
| 0008-0100-01 | 1 VIAL, SINGLE-DOSE in 1 CARTON (0008-0100-01) / 4 mL in 1 VIAL, SINGLE-DOSE |